Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1866
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

SYMPOSIUM FOR METRONOMICS AND ECONOMICS- REVIEW ARTICLE

Metronomic therapy: Chemotherapy revisited

Noronha V, Krishna M V, Patil V, Joshi A, Banavali S D, Prabhash K

Year : 2013| Volume: 50| Issue : 2 | Page no: 142-148

   This article has been cited by
 
1 Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial
V. Noronha, V. M. Patil, N. S. Menon, A. Joshi, S. Goud, S. More, S. Kannan, A. Pawar, D. Nakti, A. Yadav, S. Shah, A. Mahajan, A. Janu, R. Kumar, A. Tibdewal, N. Mummudi, J. P. Agarwal, S. D. Banavali, K. Prabhash
Esophagus. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Achievements and challenges in the use of metronomics for the treatment of breast cancer
O. Graciela Scharovsky, María José Rico, Leandro E. Mainetti, Herman A. Perroud, Viviana R. Rozados
Biochemical Pharmacology. 2020; 175: 113909
[Pubmed]  [Google Scholar] [DOI]
3 Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
Vijay M. Patil, Vanita Noronha, Amit Joshi, Sachin Dhumal, Manoj Mahimkar, Atanu Bhattacharjee, Vikram Gota, Manish Pandey, Nandini Menon, Abhishek Mahajan, Nilesh Sable, Suman Kumar, Kavita Nawale, Sadaf Mukadam, Bhavin Solanki, Sudeep Das, Vijai Simha, George Abraham, Arun Chandrasekharan, Vikas Talreja, Hollis DSouza, Sujay Srinivas, Lakhan Kashyap, Shripad Banavali, Kumar Prabhash
Journal of Clinical Oncology. 2019; 37(32): 3032
[Pubmed]  [Google Scholar] [DOI]
4 A Commentary: Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy
Clara Bik-San Lau,Chun-Kwok Wong,Ping-Chung Leung
Journal of Cancer Therapy. 2017; 08(02): 86
[Pubmed]  [Google Scholar] [DOI]
5 Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer
Vanita Noronha,Vijay M. Patil,Amit Joshi,Anuradha Chougule,Shripad Banavali,Kumar Prabhash
Cancer Letters. 2017; 400: 267
[Pubmed]  [Google Scholar] [DOI]
6 Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma
Donna E. Reece,Young Trieu,Esther Masih-Khan,Eshetu G. Atenafu,Christine Chen,Anca Prica,Rodger Tiedemann,Suzanne Trudel,Vishal Kukreti
Clinical Lymphoma Myeloma and Leukemia. 2016; 16(7): 387
[Pubmed]  [Google Scholar] [DOI]
7 Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
Junjie Wu,David J Waxman
OncoImmunology. 2015; 4(4): e1005521
[Pubmed]  [Google Scholar] [DOI]
8 Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma
Donna E. Reece,Esther Masih-Khan,Eshetu G. Atenafu,Victor H. Jimenez-Zepeda,Peter Anglin,Christine Chen,Vishal Kukreti,Joseph R. Mikhael,Suzanne Trudel
British Journal of Haematology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
9 Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model
Junjie Wu,David J. Waxman
Cancer Letters. 2014; 353(2): 272
[Pubmed]  [Google Scholar] [DOI]
10 New insights into metronomic chemotherapy-induced immunoregulation
Yi-Bin Hao,Shan-Yong Yi,Jing Ruan,Ling Zhao,Ke-Jun Nan
Cancer Letters. 2014; 354(2): 220
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow